HPV VACCINATION PHILIPPINES DRIVE
Through HPV vaccination, you can protect yourself before cancer even begins.
GET VACCINATION TODAYOur HPV Vaccination Philippines Drive continues—focused on one goal:
👉 Prevent cervical cancer before it starts.
Following our recent screening activities, several individuals were identified with early findings—reinforcing one clear message:
👉 Prevention cannot wait.
This drive is open to:
👉 Even without symptoms, HPV infection can already be present.
Cervical cancer is one of the few cancers that can be prevented—yet it continues to affect thousands of Filipino women every year.
But cervical cancer is only part of the story.
👉 The Human Papillomavirus (HPV) is responsible not only for cervical cancer, but also for other HPV-related cancers, including:
HPV is a very common infection. Most people will be exposed at some point in their lives—often without knowing it.
In many cases, HPV causes no symptoms, especially in the early stages. However, persistent infection with high-risk HPV types can slowly lead to cancer over time.
👉 This is why prevention is critical.
Through HPV vaccination, protection begins before infection occurs.
HPV is not limited to cervical cancer.
It is also linked to cancers of the throat, anus, and genital areas—conditions that affect both women and men.
One well-known case is Michael Douglas, who publicly shared that his throat cancer was associated with HPV infection.
His case highlights an important reality:
👉 HPV can be transmitted through intimate skin-to-skin contact, including oral contact
👉 It can affect areas beyond the cervix
👉 And it often develops without early symptoms
Like many HPV-related cancers, his condition was detected only after symptoms appeared—reinforcing the importance of early prevention rather than late detection
👉 HPV does not choose gender or organ—it affects both men and women, often silently.
In the Philippines, screening rates remain low, and many women are diagnosed only when the disease is already advanced.
Every day, around 12 Filipino women die from cervical cancer—a largely preventable disease.
Vaccination provides an opportunity to change this outcome—not only for cervical cancer, but for multiple HPV-related cancers.
There are many types of HPV, but only some are considered high-risk for cancer.
Recent Philippine data has shown that HPV type 52 is among the most common strains found locally.
👉 This is important because not all vaccines cover this type.
The 9-valent HPV vaccine (HPV 9) protects against:
👉 This broader protection makes it particularly relevant in the Philippine setting.
HPV vaccination is designed to protect against infection from high-risk HPV types before exposure.
It works by helping the body develop immunity against the virus—reducing the risk of developing HPV-related cancers later in life.
👉 The vaccine prevents infection, but it does not treat existing HPV.
This is why early vaccination is strongly recommended.
The HPV vaccine protects against the Human Papillomavirus, a virus that spreads through intimate skin-to-skin contact.
👉 Vaccination builds protection before exposure, reducing long-term risk.
HPV vaccination is recommended for:
Even if you are already sexually active:
👉 Vaccination may still offer protection against HPV types you have not yet encountered.
👉 The earlier the vaccination is given, the greater the protective benefit.
When the Gardasil 9 was first introduced in the Philippines around 2017, the cost ranged between ₱9,000 to ₱12,000 per dose. At that time, distribution was limited and demand was low, which contributed to higher pricing.
Today, the landscape has changed.
With wider availability through clinics and pharmacies such as Mercury Drug and Watsons, prices have become more accessible:
This reduction reflects improved access and awareness.
A common question we hear is:
👉 “Bakit mas mura? Totoo ba ito?”
The answer is simple:
👉 The vaccine is the same—what changed is access, distribution, and demand.
Yes.
Gardasil 9 protects against 9 HPV types, including those responsible for the majority of cervical cancer cases.
It provides:
👉 Protection can reach up to ~90% against cervical cancer-causing HPV types
However, an important reminder:
👉 Vaccination does not replace screening.
Women aged 25–30 years and above should still undergo regular cervical cancer screening, as there are HPV types not covered by the vaccine and infections that may have already occurred prior to vaccination.
The number of doses depends on age:
For individuals who may have difficulty completing the full schedule:
👉 A single-dose approach may still offer some level of protection,
but current evidence shows that 2–3 doses provide stronger and more durable protection.
Yes.
The HPV vaccine has been extensively studied and is widely used worldwide. It has a strong safety profile and is recommended by global health authorities.
In clinical practice and community vaccination programs, serious side effects are rare.
Most side effects are mild and temporary, including:
Some patients note that the injection may feel slightly more painful due to the thickness of the vaccine, but this usually resolves within a few minutes.
Patients are typically observed briefly after vaccination before being discharged.
Yes.
While HPV vaccination is ideally given at a younger age—before exposure to the virus—it can still be given beyond age 26.
👉 The benefit is continued protection against HPV types you may not have been exposed to.
Even for individuals who are:
vaccination may still provide added protection.